Skip to main content

Leptin

Regulation and Clinical Applications

  • Book
  • © 2015

Overview

  • Emphasizes metabolic pathophysiology and clinical applications of leptin in humans

  • Presents therapeutic trials of recombinant leptin replacement in humans for a variety of disorders

  • Considers the future direction of human leptin research and treatment possibilities

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 chapters)

Keywords

About this book

Twenty years after its discovery, recombinant human leptin has been approved by the Food and Drug Administration for the treatment of patients with lipodystrophy. Beginning with a synthesis of the vast body of work on its discovery, dissection of mechanisms, and effects in experimental models , the focus of this book shifts to a consideration of the regulation and role of leptin in humans. The emphasis on human-level data is a unique feature of this book. The results of numerous studies indicate that leptin is indeed a regulated human hormone.

Leptin provides a detailed account of the myriad physiological, hormonal, metabolic, immunological, mitogenic and inflammatory modulators and targets of leptin in a single volume. Next follows a comprehensive presentation of the therapeutic trials of recombinant leptin in patients with congenital leptin deficiency, lipodystrophy, hypothalamic amenorrhea, and other emerging areas, including leptin supplementation in leptin-replete subjects, leptin substitution for insulin in diabetic models, and novel combination regimens of leptin and other biogenic peptides. Unanswered questions and future directions in leptin research are highlighted in the Foreword by Dr. Jeffrey Friedman and throughout the volume. Identifying such questions helps direct research that could deepen understanding of the complex regulation of leptin under physiological and pathological conditions, a critical prerequisite to its rational deployment in the treatment of human disorders.

Editors and Affiliations

  • Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, USA

    Sam Dagogo-Jack, MD

About the editor

Sam Dagogo-Jack, MD, FRCP, A.C. Mullins Chair in Translational Research, Professor of Medicine and Director, Division of Endocrinology, Diabetes and Metabolism, Director, General Clinical Research Center, The University of Tennessee Health Science Center, Memphis, TN, USA

Bibliographic Information

  • Book Title: Leptin

  • Book Subtitle: Regulation and Clinical Applications

  • Editors: Sam Dagogo-Jack, MD

  • DOI: https://doi.org/10.1007/978-3-319-09915-6

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2015

  • Hardcover ISBN: 978-3-319-09914-9Published: 03 December 2014

  • Softcover ISBN: 978-3-319-35413-2Published: 23 August 2016

  • eBook ISBN: 978-3-319-09915-6Published: 18 November 2014

  • Edition Number: 1

  • Number of Pages: XXIII, 287

  • Number of Illustrations: 21 b/w illustrations, 27 illustrations in colour

  • Topics: Endocrinology, Metabolic Diseases

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Publish with us